Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.
Weidinger S, Blauvelt A, Papp KA, Reich A, Lee CH, Worm M, Lynde C, Kataoka Y, Foley P, Wei X, Wong W, Solente AC, Weber C, Adelman S, Davey S, Hurbin F, Rynkiewicz N, Yen K, O'Malley JT, Bernigaud C. Weidinger S, et al. Among authors: lynde c. J Allergy Clin Immunol. 2024 Nov 8:S0091-6749(24)01175-8. doi: 10.1016/j.jaci.2024.10.031. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39522654 Free article.
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial.
Piliang M, Lynde C, King B, Mirmirani P, Sinclair R, Senna M, Forman S, Bordone L, De La Cueva Dobao P, Wolk R, Zwillich SH, Tran H, Wajsbrot D, Ahmed HM, Takiya L. Piliang M, et al. Among authors: lynde c. J Am Acad Dermatol. 2024 Oct 17:S0190-9622(24)03006-8. doi: 10.1016/j.jaad.2024.09.064. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39423930 Free article.
Correction: Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.
Korge B, Vanhooteghem O, Lynde CW, Machovcova A, Perrussel M, Lazaridou E, Marasca C, Sarro DV, Pousa ID, Fierens F, Williams P, Shimizu S, Heidbrede T, Warren RB. Korge B, et al. Among authors: lynde cw. Dermatol Ther (Heidelb). 2024 Oct;14(10):2923-2926. doi: 10.1007/s13555-024-01271-4. Dermatol Ther (Heidelb). 2024. PMID: 39340697 Free PMC article. No abstract available.
Considerations for defining and diagnosing generalized pustular psoriasis.
Prajapati VH, Lynde CW, Gooderham MJ, Hong HC, Kirchhof MG, Lansang P, Ringuet J, Turchin I, Vender R, Yeung J, Papp KA. Prajapati VH, et al. Among authors: lynde cw. J Eur Acad Dermatol Venereol. 2024 Sep 6. doi: 10.1111/jdv.20310. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39239977 Review.
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial.
Armstrong AW, Gooderham M, Lynde C, Maari C, Forman S, Green L, Laquer V, Zhang X, Franchimont N, Gangolli EA, Blau J, Zhao Y, Zhang W, Srivastava B, Heap G, Papp K. Armstrong AW, et al. Among authors: lynde c. JAMA Dermatol. 2024 Oct 1;160(10):1066-1074. doi: 10.1001/jamadermatol.2024.2701. JAMA Dermatol. 2024. PMID: 39167366 Free PMC article. Clinical Trial.
314 results